Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma

PURPOSE: Patients with unresectable dedifferentiated liposarcoma (DDLPS) have poor overall outcomes. Few genomic alterations have been identified with limited therapeutic options. EXPERIMENTAL DESIGN: Patients treated at Levine Cancer Institute with DDLPS were identified. Next generation sequencing...

Descripción completa

Detalles Bibliográficos
Autores principales: Jagosky, Megan H., Anderson, Colin J., Symanowski, James T., Steuerwald, Nury M., Farhangfar, Carol J., Baldrige, Emily A., Benbow, Jennifer H., Livingston, Michael B., Patt, Joshua C., Ahrens, Will A., Kneisl, Jeffrey S., Kim, Edward S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067084/
https://www.ncbi.nlm.nih.gov/pubmed/36464833
http://dx.doi.org/10.1002/cam4.5502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067084/
https://www.ncbi.nlm.nih.gov/pubmed/36464833
http://dx.doi.org/10.1002/cam4.5502

Ejemplares similares